Human osteoarthritis (OA) is a progressive joint disease characterized by degradation of articular cartilage. Other key features normally occurring during OA development include thickening of the subchondral bone, formation of osteophyte, variable degrees of inflammation of the synovium, degeneration of ligaments and the menisci, and hypertrophy of the joint capsule. However, the consequence and relationship among these events are currently unknown. TGF? signaling plays a critical role in controlling chondrocyte differentiation. It has been reported that inhibition of TGF? signaling causes severe OA-like phenotype in mice. Recent genetic studies also demonstrated that mutations of the Smad3 gene are associated with high incidence of hip and knee OA in patients. However, the key downstream target genes of TGF? signaling in articular chondrocytes during OA development remains to be determined. Our preliminary studies demonstrated that chondrocyte-specific deletion of the type II TGF? receptor gene (Tgfbr2) at postnatal/adult stages lead to development of a severe OA-like phenotype. Tgfbr2 conditional knockout (Tgfbr2Col2ER) mice display the most important features of OA. In these mice Runx2 and Atf4 expression was significantly increased. We further demonstrated that inhibition of TGF? signaling up regulates Mmp13 and Adamts5 expression. We generated Tgfbr2/Mmp13 and Tgfbr2/Adamts5 double knockout mice and demonstrated that deletion of either the Mmp13 or Adamts5 gene in the Tgfbr2Col2ER background significantly reversed the majority of the OA features observed in Tgfbr2Col2ER mice. Based on these observations, we hypothesize that Runx2, with ATF4, plays a central role in activation of Mmp13 and Adamts5 expression (MMP13 and ADAMTS5 are two key enzymes in cartilage matrix degradation) and consequently leading to OA development in Tgfbr2Col2ER mice. In the proposed studies we will determine the signaling mechanism of the TGF? inhibition->Runx2/ATF4->Mmp13/Adamts5 pathway in articular chondrocytes using comprehensive molecular and genetic approaches. We have proposed three specific aims to test our hypothesis.
In Specific Aim 1 : we will determine the role of TGF? signaling in OA development in adult mice. Our hypothesis is that deletion of the Tgfbr2 gene in articular chondrocytes of adult mice leads to OA-like morphological changes and pain-related behavioral changes in adult Tgfbr2Col2ER mice.
In Specific Aim 2 : we will determine the role of Mmp13 in Tgfbr2Col2ER-induced OA phenotype. Our hypothesis is that TGF? signaling inhibition-induced Mmp13 expression is mediated by transcription factors Runx2 and ATF4.
In Specific Aim 3 : we will determine the role of Adamts5 in Tgfbr2Col2ER-induced OA phenotype. Our hypothesis is that deletion of Adamts5/Mmp13 genes in Tgfbr2Col2ER mice will have better protective effect than deletion of Mmp13 and Adamts5 alone on Tgfbr2Col2ER-induced articular cartilage degradation. Our proposed studies will provide novel insights into the molecular mechanisms of OA development.

Public Health Relevance

Osteoarthritis (OA) is a degenerative joint disease and the mechanism of this disease is poorly understood. Recent human genetic studies showed that TGF? signaling may play a key role in OA development. In the proposed studies, we will use molecular biology and mouse genetic approaches to investigate the role of TGF? signaling in OA pathogenesis. The TGF? type II receptor gene (Tgfbr2) will be specifically deleted in articular chondrocytes at adult stage in mice. Our studies will provide direct genetic evidence and molecular mechanism on the function of TGF? signaling in OA development.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Program Officer
Tyree, Bernadette
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Rush University Medical Center
Schools of Medicine
United States
Zip Code
Zhang, Yifeng; Xu, Jiankun; Ruan, Ye Chun et al. (2016) Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats. Nat Med 22:1160-1169
Liu, Y-D; Yang, H-X; Liao, L-F et al. (2016) Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. Osteoarthritis Cartilage 24:178-87
Oh, Chun-do; Im, Hee-Jeong; Suh, Joon et al. (2016) Rho-Associated Kinase Inhibitor Immortalizes Rat Nucleus Pulposus and Annulus Fibrosus Cells: Establishment of Intervertebral Disc Cell Lines With Novel Approaches. Spine (Phila Pa 1976) 41:E255-61
Xie, Wanqing; Zhou, Lijiang; Li, Shan et al. (2016) Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis. Ann N Y Acad Sci 1364:25-31
Wang, Ting Yu; Chen, Di (2016) Differential roles of TGF-β signalling in joint tissues during osteoarthritis development. Ann Rheum Dis 75:e72
Oh, Chun-do; Yasuda, Hideyo; Zhao, Weiwei et al. (2016) SOX9 directly Regulates CTGF/CCN2 Transcription in Growth Plate Chondrocytes and in Nucleus Pulposus Cells of Intervertebral Disc. Sci Rep 6:29916
Zhao, Weiwei; Zhang, Shanxing; Wang, Baoli et al. (2016) Runx2 and microRNA regulation in bone and cartilage diseases. Ann N Y Acad Sci 1383:80-87
Jin, Hongting; Wang, Baoli; Li, Jia et al. (2015) Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling. Bone 71:63-75
Yang, T; Zhang, J; Cao, Y et al. (2015) Wnt5a/Ror2 mediates temporomandibular joint subchondral bone remodeling. J Dent Res 94:803-12
Wu, Chuanyue; Jiao, Hongli; Lai, Yumei et al. (2015) Kindlin-2 controls TGF-β signalling and Sox9 expression to regulate chondrogenesis. Nat Commun 6:7531

Showing the most recent 10 out of 96 publications